ANCEF Drug Patent Profile
✉ Email this page to a colleague
When do Ancef patents expire, and when can generic versions of Ancef launch?
Ancef is a drug marketed by Glaxosmithkline and Baxter Hlthcare and is included in three NDAs.
The generic ingredient in ANCEF is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ancef
A generic version of ANCEF was approved as cefazolin sodium by SANDOZ on December 9th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ANCEF?
- What are the global sales for ANCEF?
- What is Average Wholesale Price for ANCEF?
Summary for ANCEF
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 64 |
| Patent Applications: | 2,824 |
| DailyMed Link: | ANCEF at DailyMed |
US Patents and Regulatory Information for ANCEF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | ANCEF | cefazolin sodium | INJECTABLE;INJECTION | 050461-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare | ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER | cefazolin sodium | INJECTABLE;INJECTION | 050566-004 | Jun 8, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | ANCEF | cefazolin sodium | INJECTABLE;INJECTION | 050461-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare | ANCEF IN PLASTIC CONTAINER | cefazolin sodium | INJECTABLE;INJECTION | 063002-001 | Mar 28, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
